The role of procalcitonin in neonatal intensive care unit patients with candidemia

Folia Microbiologica

Volumn 58, Issue 1, 2013, Pages 27-31

  Montagna, Maria Teresa ^a   Coretti, Caterina ^a   Rella, Antonella ^a   Barbuti, Giovanna ^a   Manca, Fabio ^a   Montagna, Osvaldo ^a   Laforgia, Nicola ^a   Caggiano, Giuseppina ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ARTICLE; BLOOD; CANDIDEMIA; FEMALE; HUMAN; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

CALCITONIN; CANDIDEMIA; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

BACTERIA (MICROORGANISMS); CANDIDA;

EID: 84871272493     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-012-0169-7     Document Type: Article

References (27)

1. Assicot M, Gendrel D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518.
2. Beaune G, Bienvenu F, Pondarré C et al (1998) Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection 26: 168-169.
3. Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 36: 941-952.
4. Benjamin DK Jr, Ross K, McKinney E Jr et al (2000) When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106: 712-718.
5. Benjamin DK, DeLong ER, Steinbach WJ et al (2003) Empirical therapy for neonatal candidemia in VLBW infants. Pediatrics 112: 543-547.
6. Charles PE, Castro C, Ruiz-Santana S et al (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp new clues for the early recognition of invasive candidiasis? Intensive Care Med 35: 2146-2150.
7. Chiesa C, Signore F, Assumma M et al (2001) Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: Reference intervals and analysis of maternal and perinatal confounders. Clin Chem 47: 1016-1022.
8. Christofilopoulou S, Charvalos E, Petrikkos G (2002) Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 13: 493-495.
9. Connell TG, Rele M, Cowley D et al (2007) How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Paediatrics 119: 891-896.
10. Di Stefano G, Curreri R, Betta P et al (2004) Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants. Acta Paediatr 93: 216-219.
11. Dornbusch HJ, Strenger V, Kerbl R et al (2005) Procalcitonin-a marker of invasive fungal infection? Support Care Cancer 13: 343-346.
12. Huber W, Schweigart U, Bottermann P (1997) Failure of PCT to indicate severe fungal infection in two immunodeficient patients. Infection 25: 377-378.
13. Marchini G, Berggren V, Djilali-Merzoug R et al (2000) The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr 89: 1082-1086.
14. Martini A, Gottin L, Menestrina N et al (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60: 425-430.
15. Meisner M, Tschaikowsky K, Palmaers T et al (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3: 45-50.
16. Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323: 17-29.
17. Montagna MT, Coretti C, Caggiano G (2011) Procalcitonin: a possible marker of invasive fungal infection in high risk patients? J Prev Med Hyg 52: 38-39.
18. Mularoni A, Furfaro E, Faraci M et al (2010) High levels of beta-d-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol 17: 882-883.
19. Nijsten MW, Olinga P, The TH et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28: 458-461.
20. Oberhoffer M, Stonans I, Russwurm S et al (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134: 49-55.
21. Oliveri S, Trovato L, Betta P et al (2008) Experience with the platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 14: 391-393.
22. Rabalais GP, Samiec TD, Bryant KK et al (1996) Invasive candidiasis in infants weighing more than 2, 500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 15: 348-352.
23. Schneider HG, Lam QT (2007) Procalcitonin for the clinical laboratory: a review. Pathology 39: 383-390.
24. Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39: 206-217.
25. Smith H, Congdon P (1985) Neonatal systemic candidiasis. Arch Dis Child 60: 365-369.
26. Turner D, Hammerman C, Rudensky B et al (2006) The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr 95: 1571-1576.
27. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4: 620-630.